These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4588974)

  • 1. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK
    Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled study on the effect of a new substance in peripheral arterial diseases].
    Poti R; Megha A; Pini M; Bulletti G
    Minerva Cardioangiol; 1974; 22(7-8):574-87. PubMed ID: 4605589
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with Dilangio in patients with reflex sympathetic algodystrophia of the extremities].
    Velasco Domínguez E
    Rev Esp Reum Enferm Osteoartic; 1974; 17(3):200-11. PubMed ID: 4438804
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of peripheral circulation disorders with 1-benzyl-1-(3-dimethyl-amino-propoxy)-cycloheptane].
    Denck H
    Wien Med Wochenschr; 1973 Mar; 123(11):174-8. PubMed ID: 4692075
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition of thrombocyte adhesion by bencyclane: experimental and clinical results.
    Martin M; Schäfer G; Martin U; Juraschek H; Knüll W
    Thromb Res; 1974 Jun; 4(6):741-52. PubMed ID: 4844058
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of peripheral circulation disorders. Double-blind study on the effect of fludilat].
    König FK
    Med Welt; 1972 May; 23(20):763-8. PubMed ID: 5037194
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
    Trübestein G; Trübestein R; Ludwig M
    Fortschr Med; 1989 Dec; 107(36):781-4. PubMed ID: 2695437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic arterial insufficiency of lower limbs: treatment by bencyclan (fludilat) (author's transl)].
    Krähenbühl B
    Schweiz Rundsch Med Prax; 1975 May; 64(20):632-4. PubMed ID: 1099573
    [No Abstract]   [Full Text] [Related]  

  • 11. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G; Balzer K; Bisler H; Klüken N; Mahfoud Y; Müller-Wiefel H; Unkel B; Ziegler W
    Dtsch Med Wochenschr; 1982 Dec; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
    Masini G
    Minerva Cardioangiol; 1975 Feb; 23(2):120-5. PubMed ID: 1095956
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
    Battke K; Buchwalsky R; Barmeyer J; Hoffmann G; Reindell H
    Fortschr Med; 1978 Jul; 96(26-27):1381-6. PubMed ID: 669532
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
    Saponaro A; Russo R; Tomei F; Giordano M; Dragagna G; Barbato G
    Clin Ter; 1979 Dec; 91(6):585-92. PubMed ID: 544162
    [No Abstract]   [Full Text] [Related]  

  • 15. [Piribedil in arterial diseases].
    Cristol R; Arnaud F
    Nouv Presse Med; 1974 Nov 30-Dec 14; 3(41-43):2573-4. PubMed ID: 4619431
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral arterial disease: drug therapy.
    Schwartz JB
    J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V; Mammarella A; Alessandrini A; Barlattani M
    Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
    Horsch S; Claeys L
    Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
    [No Abstract]   [Full Text] [Related]  

  • 19. [Double-blind study on piribedil in peripheral arterial diseases].
    Milliken JC; Fares CM; O'Connor D
    Minerva Med; 1976 May; 67(25):1662-7. PubMed ID: 778668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM; Lepore R
    Clin Ter; 1990 Nov; 135(4):273-81. PubMed ID: 2150026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.